Is NYXH or ICCM more profitable?

IceCure Medical has a net margin of -441.60% compared to Nyxoah's net margin of -543.21%. Nyxoah's return on equity of -163.73% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -543.21% -163.73% -80.24% IceCure Medical -441.60% -211.73% -119.13%

Does the media favor NYXH or ICCM?

In the previous week, Nyxoah had 6 more articles in the media than IceCure Medical. MarketBeat recorded 9 mentions for Nyxoah and 3 mentions for IceCure Medical. Nyxoah's average media sentiment score of 0.57 beat IceCure Medical's score of 0.29 indicating that Nyxoah is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IceCure Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DXR or ICCM?

IceCure Medical has a consensus price target of $62.70, suggesting a potential upside of 1,617.81%. Given IceCure Medical's higher probable upside, analysts plainly believe IceCure Medical is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has preferable valuation and earnings, DXR or ICCM?

Daxor has higher earnings, but lower revenue than IceCure Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Daxor N/A N/A N/A N/A N/A IceCure Medical $3.38M 3.70 -$15.06M -$7.21 N/A

Is DXR or ICCM more profitable?

Daxor has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Daxor's return on equity of 0.00% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets Daxor N/A N/A N/A IceCure Medical -441.60% -211.73% -119.13%

Does the media favor DXR or ICCM?

In the previous week, Daxor and Daxor both had 3 articles in the media. Daxor's average media sentiment score of 0.96 beat IceCure Medical's score of 0.29 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IceCure Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ICCM or APT?

IceCure Medical currently has a consensus price target of $62.70, indicating a potential upside of 1,617.81%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe IceCure Medical is more favorable than Alpha Pro Tech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate ICCM or POCI?

IceCure Medical currently has a consensus price target of $62.70, suggesting a potential upside of 1,617.81%. Given IceCure Medical's stronger consensus rating and higher possible upside, research analysts plainly believe IceCure Medical is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

IceCure Medical (ICCM) Competitors

$3.65 -0.24 (-6.17%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$3.72 +0.07 (+1.84%)

As of 07/10/2026 07:58 PM Eastern

Compare

ICCM vs. NYXH, COCH, DXR, APT, and POCI

Should you buy IceCure Medical stock or one of its competitors? MarketBeat compares IceCure Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IceCure Medical include Nyxoah (NYXH), Envoy Medical (COCH), Daxor (DXR), Alpha Pro Tech (APT), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

How does IceCure Medical compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

IceCure Medical has lower revenue, but higher earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	5.85	-$101.92M	-$2.48	N/A
IceCure Medical	$3.38M	3.70	-$15.06M	-$7.21	N/A

Nyxoah currently has a consensus price target of $5.96, indicating a potential upside of 248.68%. IceCure Medical has a consensus price target of $62.70, indicating a potential upside of 1,617.81%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

IceCure Medical has a net margin of -441.60% compared to Nyxoah's net margin of -543.21%. Nyxoah's return on equity of -163.73% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
IceCure Medical	-441.60%	-211.73%	-119.13%

In the previous week, Nyxoah had 6 more articles in the media than IceCure Medical. MarketBeat recorded 9 mentions for Nyxoah and 3 mentions for IceCure Medical. Nyxoah's average media sentiment score of 0.57 beat IceCure Medical's score of 0.29 indicating that Nyxoah is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nyxoah	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IceCure Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nyxoah has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

0.6% of IceCure Medical shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Nyxoah beats IceCure Medical on 9 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Envoy Medical?

IceCure Medical (NASDAQ:ICCM) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

IceCure Medical has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	3.70	-$15.06M	-$7.21	N/A
Envoy Medical	$240K	218.88	-$23.76M	-$1.01	N/A

IceCure Medical has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market.

IceCure Medical presently has a consensus target price of $62.70, indicating a potential upside of 1,617.81%. Envoy Medical has a consensus target price of $2.50, indicating a potential upside of 265.87%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IceCure Medical has a net margin of -441.60% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Envoy Medical	-9,875.64%	N/A	-177.92%

In the previous week, IceCure Medical had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for IceCure Medical and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat IceCure Medical's score of 0.29 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
IceCure Medical	Neutral
Envoy Medical	Very Positive

Summary

IceCure Medical beats Envoy Medical on 9 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Daxor?

Daxor (NASDAQ:DXR) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

Daxor has higher earnings, but lower revenue than IceCure Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
IceCure Medical	$3.38M	3.70	-$15.06M	-$7.21	N/A

In the previous week, Daxor and Daxor both had 3 articles in the media. Daxor's average media sentiment score of 0.96 beat IceCure Medical's score of 0.29 indicating that Daxor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Daxor	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IceCure Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Daxor has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Daxor's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
IceCure Medical	-441.60%	-211.73%	-119.13%

1.3% of Daxor shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 51.5% of Daxor shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Daxor has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

IceCure Medical has a consensus price target of $62.70, suggesting a potential upside of 1,617.81%. Given IceCure Medical's higher probable upside, analysts plainly believe IceCure Medical is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Daxor beats IceCure Medical on 7 of the 11 factors compared between the two stocks.

How does IceCure Medical compare to Alpha Pro Tech?

IceCure Medical (NASDAQ:ICCM) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 16.2% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IceCure Medical currently has a consensus price target of $62.70, indicating a potential upside of 1,617.81%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe IceCure Medical is more favorable than Alpha Pro Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alpha Pro Tech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

IceCure Medical has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Alpha Pro Tech has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	3.70	-$15.06M	-$7.21	N/A
Alpha Pro Tech	$59.91M	0.86	$4.19M	$0.35	14.46

In the previous week, IceCure Medical had 3 more articles in the media than Alpha Pro Tech. MarketBeat recorded 3 mentions for IceCure Medical and 0 mentions for Alpha Pro Tech. IceCure Medical's average media sentiment score of 0.29 beat Alpha Pro Tech's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company	Overall Sentiment
IceCure Medical	Neutral
Alpha Pro Tech	Neutral

Alpha Pro Tech has a net margin of 6.99% compared to IceCure Medical's net margin of -441.60%. Alpha Pro Tech's return on equity of 6.70% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Alpha Pro Tech	6.99%	6.70%	5.76%

Summary

Alpha Pro Tech beats IceCure Medical on 10 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Precision Optics?

IceCure Medical (NASDAQ:ICCM) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

IceCure Medical has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market.

Precision Optics has higher revenue and earnings than IceCure Medical. Precision Optics is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	3.70	-$15.06M	-$7.21	N/A
Precision Optics	$19.09M	2.85	-$5.78M	-$0.63	N/A

In the previous week, IceCure Medical had 2 more articles in the media than Precision Optics. MarketBeat recorded 3 mentions for IceCure Medical and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.89 beat IceCure Medical's score of 0.29 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Overall Sentiment
IceCure Medical	Neutral
Precision Optics	Very Positive

IceCure Medical currently has a consensus price target of $62.70, suggesting a potential upside of 1,617.81%. Given IceCure Medical's stronger consensus rating and higher possible upside, research analysts plainly believe IceCure Medical is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Precision Optics has a net margin of -17.03% compared to IceCure Medical's net margin of -441.60%. Precision Optics' return on equity of -37.47% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Precision Optics	-17.03%	-37.47%	-19.96%

Summary

Precision Optics beats IceCure Medical on 9 of the 16 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICCM vs. The Competition

Export

Metric	IceCure Medical	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$12.51M	$9.60B	$7.09B	$12.66B
Dividend Yield	N/A	1.62%	2.68%	8.00%
P/E Ratio	-0.51	26.41	27.42	24.53
Price / Sales	3.70	18.14	528.33	96.17
Price / Cash	N/A	111.75	48.47	60.03
Price / Book	0.98	6.05	10.88	6.38
Net Income	-$15.06M	$179.69M	$3.59B	$331.87M
7 Day Performance	-31.90%	-1.68%	-0.26%	0.37%
1 Month Performance	52.72%	7.36%	4.55%	0.59%
1 Year Performance	-88.30%	11.95%	29.86%	22.26%

IceCure Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICCM IceCure Medical	2.7954 of 5 stars	$3.65 -6.2%	$62.70 +1,617.8%	-88.3%	$12.51M	$3.38M	N/A	60	Short Interest Increase Gap Down
NYXH Nyxoah	3.5137 of 5 stars	$1.69 +2.4%	$7.00 +314.2%	-77.4%	$65.51M	$15.33M	N/A	110	Analyst Forecast Short Interest Decrease
COCH Envoy Medical	2.7801 of 5 stars	$0.79 +16.0%	$2.50 +215.7%	-55.9%	$60.89M	$240K	N/A	34	Positive News
DXR Daxor	1.9262 of 5 stars	$10.13 +0.2%	N/A	+10.7%	$59.14M	$10.30M	N/A	37	Short Interest Decrease
APT Alpha Pro Tech	N/A	$5.62 +1.3%	N/A	+5.6%	$57.42M	$59.91M	15.19	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICCM) was last updated on 7/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IceCure Medical (ICCM) Competitors

ICCM vs. NYXH, COCH, DXR, APT, and POCI

How does IceCure Medical compare to Nyxoah?

Summary

How does IceCure Medical compare to Envoy Medical?

Summary

How does IceCure Medical compare to Daxor?

Summary

How does IceCure Medical compare to Alpha Pro Tech?

Summary

How does IceCure Medical compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICCM vs. The Competition

IceCure Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IceCure Medical (ICCM) Competitors

ICCM vs. NYXH, COCH, DXR, APT, and POCI

How does IceCure Medical compare to Nyxoah?

Which has better earnings & valuation, NYXH or ICCM?

Do analysts rate NYXH or ICCM?

Is NYXH or ICCM more profitable?

Does the media favor NYXH or ICCM?

Which has more volatility and risk, NYXH or ICCM?

Do insiders & institutionals have more ownership in NYXH or ICCM?

Summary

How does IceCure Medical compare to Envoy Medical?

Do insiders and institutionals believe in ICCM or COCH?

Which has stronger earnings and valuation, ICCM or COCH?

Which has more risk and volatility, ICCM or COCH?

Do analysts prefer ICCM or COCH?

Is ICCM or COCH more profitable?

Does the media refer more to ICCM or COCH?

Summary

How does IceCure Medical compare to Daxor?

Which has preferable valuation and earnings, DXR or ICCM?

Does the media favor DXR or ICCM?

Is DXR or ICCM more profitable?

Do insiders & institutionals believe in DXR or ICCM?

Which has more risk & volatility, DXR or ICCM?

Do analysts prefer DXR or ICCM?

Summary

How does IceCure Medical compare to Alpha Pro Tech?

Do insiders and institutionals have more ownership in ICCM or APT?

Do analysts rate ICCM or APT?

Which has more volatility & risk, ICCM or APT?

Which has preferable valuation & earnings, ICCM or APT?

Does the media refer more to ICCM or APT?

Is ICCM or APT more profitable?

Summary

How does IceCure Medical compare to Precision Optics?

Which has more volatility and risk, ICCM or POCI?

Which has better earnings & valuation, ICCM or POCI?

Does the media refer more to ICCM or POCI?

Do analysts rate ICCM or POCI?

Do insiders & institutionals believe in ICCM or POCI?

Is ICCM or POCI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICCM vs. The Competition

IceCure Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools